Table 2.
(a) Correlation of standardized uptake value on 5-flurodeoxyglucose positron emission tomography computed tomography and estrogen receptor expression on immunohistochemistry (b) correlation of standardized uptake value on 18F-fluoroestradiol positron emission tomography computed tomography and estrogen receptor expression on immunohistochemistry
| a. FDG PET CT - ER correlation | |||||||
|---|---|---|---|---|---|---|---|
| Variable | SUV tumor | SUV I/L LN | SUV C/L LN | SUV IM LN | SUV metastasis | Tumor-to- background ratio | |
| Correlation coefficient with ER score (Spearman’s Rho) | −0.3808 | −0.7853 | 0.999 | −0.3162 | 0.8721 | −0.2117 | |
| P | 0.1456 | 0.0003 | 0.025 | 0.6838 | 0.0539 | 0.4311 | |
| b. FES PET CT - ER correlation | |||||||
| Variable | SUV tumor | SUV I/L LN | SUV C/L LN | SUV IM LN | SUV metastasis | Tumor-to- background ratio | Visual interpretation grading |
| Correlation coefficient with ER score (Spearman’s Rho) | 0.5305 | 0.2668 | 0.404 | 0.5000 | −0.1026 | 0.6640 | 0.7737 |
| P | 0.0111 | 0.2845 | 0.735 | 0.6667 | 0.8696 | 0.0008 | 0.0000 |
SUV: Standardized uptake value; I/L LN: Ipsilateral lymph node; C/L LN: Contralateral lymph node; ER: Estrogen receptor; FDG: 5-flurodeoxyglucose; PET: Positron emission tomography; CT: Computed tomography; IM: Internal mammary; FES: 18F-fluoroestradiol